PCCM Tools | PERT Team Support

Case Discussion Capture (De-identified)

Optional: record a case discussion first. The captured text is scrubbed for likely identifiers and merged with key structured inputs into a copy-ready narrative for external AI tools.

Mobile note: native phone keyboard dictation inside the text box is often more accurate than browser-based live listening. If live capture is inconsistent on your phone, tap into the narrative box and use the device microphone on the keyboard.

Reminder: during case discussion, avoid patient identifiers such as name, medical record number, birth date, and similar details.

Microphone transcription idle.

De-identified case narrative (editable)

Patient Context

PERT Discussion Date/Time

Age (years)

Gender

Actual body weight (kg)

Symptomatic acute PE

Diagnosis status

Most proximal clot location

VTE provoking factor profile

Incidentally discovered PE (imaging for another reason) Imaging delayed / not immediately accessible Clot-in-transit (right atrium / RV) Recurrent PE despite therapeutic anticoagulation

Hemodynamics, Perfusion, and Key Laboratory Data

Heart rate (bpm)

Systolic BP (mm Hg)

Temperature (°C)

Estimated creatinine clearance (mL/min)

MAP (mm Hg)

Lactate (mmol/L)

Vasopressor support

Persistent/recurrent hypotension or shock Transient hypotension (SBP <90 or drop >40 mm Hg lasting <15 min or responsive to IV fluids) Cardiac arrest / prolonged failed ROSC Acute kidney injury or urine output <0.5 mL/kg/hr Mental status change Cardiac index <2.2 L/min/m² Shock score/stage increased Unable to lie flat (may preclude IR-based procedures)

RV / Biomarkers / Respiratory Status

RV dysfunction (echo or CT)

Troponin

BNP/NT-proBNP

O2 saturation (%)

Respiratory rate

Current oxygen/ventilation support

Key Comorbidities

PESI, sPESI, and Bova are calculated automatically from the entered clinical data when sufficient fields are available.

History of cancer History of heart failure Chronic lung disease

Clinical severity scores will auto-calculate when sufficient data are entered.

Bleeding Risk

Absolute contraindications to thrombolysis / VA-ECMO

Active bleeding Prior intracranial hemorrhage Suspected or confirmed aortic dissection Brain or spinal surgery within 3 months Intracranial neoplasm, vascular malformation, or other structural brain disease

Relative bleeding risk considerations

Coagulopathy (e.g., INR >1.7) Uncontrolled severe hypertension Recent major surgery (within 14 days) Recent serious trauma Pregnancy Recent gastrointestinal bleeding

Special Populations

Pregnancy Breastfeeding Active cancer Thrombotic antiphospholipid antibody syndrome Severe CKD (stage 4-5) / dialysis History of heparin-induced thrombocytopenia (HIT)